Skip to main content

Together we are beating cancer

Donate now

Science & Technology

Read the latest in pre-clinical research, drug discovery and new technologies in cancer
Showing 12 out of 1581 results
Michelle Mitchell, CEO of CRUK

For the International Day of Women and Girls in Science, Michelle Mitchell, CEO of Cancer Research UK, highlights some of the barriers facing women in research and how the charity is trying to overcome them. For the International Day of Women and Girls in Science, Michelle Mitchell, CEO of Cancer Research UK, highlights some of the barriers facing women in research and how the charity is trying to overcome them.

by Michelle Mitchell | Opinion | 11 February 2023

11 February 2023

A sculpture of a tumour made as part of the Science Museum exhibition
  • Science & Technology
  • Health & Medicine

Our most important cancer research stories of 2022

This year has been full of research, advances and people worth celebrating. Here are some of our biggest stories from the past 12 months.  This year has been full of research, advances and people worth celebrating. Here are some of our biggest stories from the past 12 months. 

by Tim Gunn | In depth | 14 December 2022

14 December 2022

Left to right: Emma Colliver, Dr William Hill and Dr Emilia Lim

We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today.  We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today. 

by Jacob Smith | Interview | 13 December 2022

13 December 2022

A man wearing a virtual reality headset

The same techniques that make video games so popular can help us treat cancer. Owen Harris, designer of a new VR tool for studying tumours, tells us how. The same techniques that make video games so popular can help us treat cancer. Owen Harris, designer of a new VR tool for studying tumours, tells us how.

by Lilly Matson | In depth | 1 December 2022

1 December 2022

Ian Walker

When the economy faces a slump, investing in research becomes an urgent priority, writes Dr Ian Walker, our executive director of policy, information and communications. When the economy faces a slump, investing in research becomes an urgent priority, writes Dr Ian Walker, our executive director of policy, information and communications.

by Ian Walker | Opinion | 16 November 2022

16 November 2022

T cell

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

by Jacob Smith | Analysis | 11 November 2022

11 November 2022

Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx.  Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx. 

by Kathryn Thompson | News | 9 November 2022

9 November 2022

Professor Carolyn Bertozzi with graduate student Mireille Kamariza

Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children. Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children.

by Tim Gunn | Analysis | 8 November 2022

8 November 2022

Tissue stain of medulloblastoma - which is densely cellular and discrete from other tissue

Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future. Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future.

by Lilly Matson | Analysis | 4 November 2022

4 November 2022

A 3D illustration of cancer cells

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination.  Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

by Jacob Smith | Analysis | 18 October 2022

18 October 2022